Our results show that anti-Mtb specific salivary IgA are detectable and vary significantly in different stages of TB infection, with highest levels obtained in individuals with established TBI and lower levels obtained in the “non-Mtb infected,” and in those exposed that later progressed into a new infection. The gene discussed is CD79A; the disease is infection.